05172024Fri
Last updateWed, 27 Mar 2024 6am

Genetics of hyperuricemia and gout: Insights from recent genome‑wide association studies and Mendelian randomization studies

Yu‑Lin Koa,b,c*

aCardiovascular Center and Division of Cardiology,Department of Internal Medicine, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan, bSchool of Medicine, Tzu Chi University, Hualien, Taiwan, cDepartment of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan
 

Download PDF

Open Access funded by Buddhist Compassion Relief Tzu Chi Foundation

 

Abstract
 
Gout is the most common form of inflammatory arthritis in adults. Elevation serum uric acid (SUA) concentration is known to be the key to gout pathogenesis. Since the first genome‑wide association study (GWAS) for SUA was performed in 2007, the number of gene loci known to be associated with hyperuricemia and gout has grown rapidly. GWASs and Mendelian randomization studies have also reported numerous novel results regarding the genetics of hyperuricemia and gout since 2018. We concisely review recent advances in scholarship on the effects of genetics on hyperuricemia and gout risk. We also review data from genetic association studies in Taiwan and perform GWASs of SUA levels among Taiwan Biobank participants.
 
Keywords: Genetics, Genome‑wide association study, Gout, Hyperuricemia, Mendelian randomization study

 

 

 

 

 
 
 
 

 

On the Cover

Search all Issue